Back to search
Rare Bleeding Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rare Bleeding Disorders trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Rare Bleeding Disorders trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The MPN PROGRESSion Registry is a multi-year, observational research study designed to improve understanding of myeloproliferative neoplasms (MPNs)-a group of r…
In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently FD…
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening disorder characterized by microangiopathic hemolytic anemia, severe thrombocytopen…
ENROL, the European Rare Blood Disorders Platform has been conceived in the core of ERN-EuroBloodNet as an umbrella for both new and already existing registries…
This study evaluates whether a personalized, supervised exercise program can improve fatigue and physical function in patients with myeloproliferative neoplasms…
The palliative care needs of family caregivers of children with rare diseases and their children are largely unmet, including the need for support to prepare fo…